Does inflammation markers or treatment type moderate exercise intensity effects on changes in muscle strength in cancer survivors participating in a 6-month combined resistance- and endurance exercise program? Results from the Phys-Can trial

BMC Sports Science, Medicine and Rehabilitation

Research

Sussanne Börjeson¹  Karin Nordin²  Anne-Sophie Mazzoni²  Emelie Strandberg²  Anna Henriksson²  Ingrid Demmelmaier³  Sveinung Berntsen³  Truls Raastad⁴  Andreas Stenling⁵  Katarina Sjövall⁶ 

[1] Department of Oncology and Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden;Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden;Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden;Department of Sport Science and Physical Education, University of Agder, Kristiansand, Norway;Department of Sport Science and Physical Education, University of Agder, Kristiansand, Norway;Department of Physical Performance, Norwegian School of Sport Science, Oslo, Norway;Department of Sport Science and Physical Education, University of Agder, Kristiansand, Norway;Department of Psychology, Umeå University, Umeå, Sweden;Faculty of Health Sciences, Kristianstad University, Kristianstad, Sweden;

关键词: Androgen deprivation therapy;    Cancer;    Chemotherapy;    Exercise intensity;    Moderators;    Inflammation;    Resistance training;   

DOI  :  10.1186/s13102-023-00617-3

 received in 2022-09-26, accepted in 2023-01-12,  发布年份 2023

来源: Springer

【 授权许可】

CC BY   
© The Author(s) 2023

【 图 表 】

Fig. 2

41116_2022_35_Article_IEq231.gif